{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T09:00:48Z","timestamp":1775898048560,"version":"3.50.1"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T00:00:00Z","timestamp":1411084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s40272-014-0091-3","type":"journal-article","created":{"date-parts":[[2014,9,18]],"date-time":"2014-09-18T20:59:33Z","timestamp":1411073973000},"page":"483-489","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Hidradenitis Suppurativa in Children and Adolescents: A Review of Treatment Options"],"prefix":"10.1007","volume":"16","author":[{"given":"Peter Riis","family":"Mikkelsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregor B. E.","family":"Jemec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,19]]},"reference":[{"issue":"2","key":"91_CR1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMcp1014163","volume":"366","author":"GB Jemec","year":"2012","unstructured":"Jemec GB. Clinical practice. Hidradenitis suppurativa. N Engl J Med. 2012;366(2):158\u201364.","journal-title":"N Engl J Med"},{"issue":"5","key":"91_CR2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1600-0625.2008.00712_10.x","volume":"17","author":"H Kurzen","year":"2008","unstructured":"Kurzen H, Kurokawa I, Jemec GB, Emtestam L, Sellheyer K, Giamarellos-Bourboulis EJ, et al. What causes hidradenitis suppurativa? Exp Dermatol. 2008;17(5):455\u20136.","journal-title":"Exp Dermatol"},{"issue":"1","key":"91_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.1985.tb02037.x","volume":"113","author":"JS Fitzsimmons","year":"1985","unstructured":"Fitzsimmons JS, Guilbert PR, Fitzsimmons EM. Evidence of genetic factors in hidradenitis suppurativa. Br J Dermatol. 1985;113(1):1\u20138.","journal-title":"Br J Dermatol"},{"issue":"3","key":"91_CR4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2133.1988.tb03227.x","volume":"119","author":"GB Jemec","year":"1988","unstructured":"Jemec GB. The symptomatology of hidradenitis suppurativa in women. Br J Dermatol. 1988;119(3):345\u201350.","journal-title":"Br J Dermatol"},{"issue":"2 Pt 1","key":"91_CR5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0190-9622(96)90321-7","volume":"35","author":"GB Jemec","year":"1996","unstructured":"Jemec GB, Heidenheim M, Nielsen NH. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol. 1996;35(2 Pt 1):191\u20134.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"91_CR6","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2340\/0001555576482483","volume":"76","author":"GB Jemec","year":"1996","unstructured":"Jemec GB, Heidenheim M, Nielsen NH. A case\u2013control study of hidradenitis suppurativa in an STD population. Acta Derm Venereol. 1996;76(6):482\u20133.","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"91_CR7","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ad.2011.07.008","volume":"103","author":"MP Albares","year":"2012","unstructured":"Albares MP, Belinchon I, Ramos JM, Sanchez-Paya J, Betlloch I. Epidemiologic study of skin diseases among immigrants in Alicante, Spain. Actas Dermosifiliogr. 2012;103(3):214\u201322.","journal-title":"Actas Dermosifiliogr"},{"issue":"5","key":"91_CR8","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jaad.2013.06.042","volume":"69","author":"I Cosmatos","year":"2013","unstructured":"Cosmatos I, Matcho A, Weinstein R, Montgomery MO, Stang P. Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States. J Am Acad Dermatol. 2013;69(5):819.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"91_CR9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/jid.2012.255","volume":"133","author":"BG Vazquez","year":"2013","unstructured":"Vazquez BG, Alikhan A, Weaver AL, Wetter DA, Davis MD. Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota. J Invest Dermatol. 2013;133(1):97\u2013103.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"91_CR10","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/bjd.12787","volume":"170","author":"GR Vinding","year":"2014","unstructured":"Vinding GR, Miller IM, Zarchi K, Ibler KS, Ellervik C, Jemec GB. The prevalence of inverse recurrent suppuration: a population-based study of possible hidradenitis suppurativa. Br J Dermatol. 2014;170(4):884\u20139.","journal-title":"Br J Dermatol"},{"issue":"12","key":"91_CR11","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/aje\/kwu078","volume":"179","author":"K McMillan","year":"2014","unstructured":"McMillan K. Hidradenitis suppurativa: number of diagnosed patients, demographic characteristics, and treatment patterns in the United States. Am J Epidemiol. 2014;179(12):1477\u201383.","journal-title":"Am J Epidemiol"},{"issue":"6","key":"91_CR12","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2230.2001.00876.x","volume":"26","author":"RA Palmer","year":"2001","unstructured":"Palmer RA, Keefe M. Early-onset hidradenitis suppurativa. Clin Exp Dermatol. 2001;26(6):501\u20133.","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"91_CR13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jpag.2005.11.006","volume":"19","author":"JD Trager","year":"2006","unstructured":"Trager JD, Kress DW, Kress DW. What\u2019s your diagnosis? Painful nodules on the perineum with scarring and sinus tract formation. J Pediatr Adolesc Gynecol. 2006;19(1):45\u20138.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"8","key":"91_CR14","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/j.1524-4725.2009.01231.x","volume":"35","author":"M Feito-Rodriguez","year":"2009","unstructured":"Feito-Rodriguez M, Sendagorta-Cudos E, Herranz-Pinto P, de Lucas-Laguna R. Prepubertal hidradenitis suppurativa successfully treated with botulinum toxin A. Dermatol Surg. 2009;35(8):1300\u20132.","journal-title":"Dermatol Surg"},{"issue":"3","key":"91_CR15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4103\/0022-3859.101403","volume":"58","author":"G Prabhu","year":"2012","unstructured":"Prabhu G, Laddha P, Manglani M, Phiske M. Hidradenitis suppurativa in a HIV-infected child. J Postgrad Med. 2012;58(3):207\u20139.","journal-title":"J Postgrad Med"},{"issue":"6","key":"91_CR16","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/jamadermatol.2013.2874","volume":"149","author":"HK Randhawa","year":"2013","unstructured":"Randhawa HK, Hamilton J, Pope E. Finasteride for the treatment of hidradenitis suppurativa in children and adolescents. JAMA Dermatol. 2013;149(6):732\u20135.","journal-title":"JAMA Dermatol"},{"issue":"1","key":"91_CR17","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.1542\/peds.2012-3356","volume":"133","author":"AC Krakowski","year":"2014","unstructured":"Krakowski AC, Admani S, Uebelhoer NS, Eichenfield LF, Shumaker PR. Residual scarring from hidradenitis suppurativa: fractionated CO2 laser as a novel and noninvasive approach. Pediatrics. 2014;133(1):e248\u201351.","journal-title":"Pediatrics"},{"issue":"1","key":"91_CR18","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jss.2013.05.056","volume":"184","author":"RM Rentea","year":"2013","unstructured":"Rentea RM, Somers KK, Cassidy L, Enters J, Arca MJ. Negative pressure wound therapy in infants and children: a single-institution experience. J Surg Res. 2013;184(1):658\u201364.","journal-title":"J Surg Res"},{"issue":"4","key":"91_CR19","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1365-2133.2001.04137.x","volume":"144","author":"JM Werth von der","year":"2001","unstructured":"von der Werth JM, Jemec GB. Morbidity in patients with hidradenitis suppurativa. Br J Dermatol. 2001;144(4):809\u201313.","journal-title":"Br J Dermatol"},{"issue":"4","key":"91_CR20","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaad.2006.08.061","volume":"56","author":"P Wolkenstein","year":"2007","unstructured":"Wolkenstein P, Loundou A, Barrau K, Auquier P, Revuz J. Quality of life impairment in hidradenitis suppurativa: a study of 61 cases. J Am Acad Dermatol. 2007;56(4):621\u20133.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"91_CR21","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2340\/00015555-0866","volume":"90","author":"L Matusiak","year":"2010","unstructured":"Matusiak L, Bieniek A, Szepietowski JC. Psychophysical aspects of hidradenitis suppurativa. Acta Derm Venereol. 2010;90(3):264\u20138.","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"91_CR22","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1468-3083.2012.04468.x","volume":"27","author":"AJ Onderdijk","year":"2013","unstructured":"Onderdijk AJ, van der Zee HH, Esmann S, Lophaven S, Dufour DN, Jemec GB, et al. Depression in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2013;27(4):473\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"91_CR23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/AJP.0b013e3181ceb80c","volume":"26","author":"HS Smith","year":"2010","unstructured":"Smith HS, Chao JD, Teitelbaum J. Painful hidradenitis suppurativa. Clin J Pain. 2010;26(5):435\u201344.","journal-title":"Clin J Pain"},{"issue":"4","key":"91_CR24","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2230.2010.03965.x","volume":"36","author":"O Bilgic","year":"2011","unstructured":"Bilgic O, Bilgic A, Akis HK, Eskioglu F, Kilic EZ. Depression, anxiety and health-related quality of life in children and adolescents with vitiligo. Clin Exp Dermatol. 2011;36(4):360\u20135.","journal-title":"Clin Exp Dermatol"},{"key":"91_CR25","doi-asserted-by":"crossref","unstructured":"Schrader AM, Deckers IE, van der Zee HH, Boer J, Prens EP. Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity. J Am Acad Dermatol. 2014.","DOI":"10.1016\/j.jaad.2014.04.001"},{"key":"91_CR26","doi-asserted-by":"crossref","unstructured":"Crowley JJ, Mekkes JR, Zouboulis CC, Scheinfeld N, Kimball A, Sundaram M, et al. Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities. Br J Dermatol. 2014.","DOI":"10.1111\/bjd.13122"},{"key":"91_CR27","doi-asserted-by":"crossref","unstructured":"Kromann CB, Deckers IE, Esmann S, Boer J, Prens EP, Jemec GB. Risk-factors, clinical course and long-term prognosis in hidradenitis suppurativa: a cross-sectional study. Br J Dermatol. 2014.","DOI":"10.1111\/bjd.13090"},{"issue":"3","key":"91_CR28","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.clindermatol.2013.11.006","volume":"32","author":"C Dessinioti","year":"2014","unstructured":"Dessinioti C, Katsambas A, Antoniou C. Hidradenitis suppurrativa (acne inversa) as a systemic disease. Clin Dermatol. 2014;32(3):397\u2013408.","journal-title":"Clin Dermatol"},{"issue":"3","key":"91_CR29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/ced.12269","volume":"39","author":"CL Thomas","year":"2014","unstructured":"Thomas CL, Gordon KD, Mortimer PS. Rapid resolution of hidradenitis suppurativa after bariatric surgical intervention. Clin Exp Dermatol. 2014;39(3):315\u20137.","journal-title":"Clin Exp Dermatol"},{"key":"91_CR30","doi-asserted-by":"crossref","unstructured":"Kromann C, Ibler KS, Kristiansen V, Jemec GB. The influence of body weight on the prevalence and severity of hidradenitis suppurativa. Acta Derm Venereol. 2014.","DOI":"10.2340\/00015555-1800"},{"issue":"4","key":"91_CR31","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jaad.2013.11.014","volume":"70","author":"DA Gold","year":"2014","unstructured":"Gold DA, Reeder VJ, Mahan MG, Hamzavi IH. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa. J Am Acad Dermatol. 2014;70(4):699\u2013703.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"91_CR32","first-page":"18558","volume":"19","author":"N Scheinfeld","year":"2013","unstructured":"Scheinfeld N. Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis. Dermatol Online J. 2013;19(6):18558.","journal-title":"Dermatol Online J"},{"issue":"6","key":"91_CR33","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/jid.2012.472","volume":"133","author":"F Canoui-Poitrine","year":"2013","unstructured":"Canoui-Poitrine F, Le TA, Revuz JE, Viallette C, Gabison G, Poli F, et al. Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a cross-sectional study. J Invest Dermatol. 2013;133(6):1506\u201311.","journal-title":"J Invest Dermatol"},{"issue":"6","key":"91_CR34","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1590\/S0365-05962012000600024","volume":"87","author":"JV Schmitt","year":"2012","unstructured":"Schmitt JV, Bombonatto G, Martin M, Miot HA. Risk factors for hidradenitis suppurativa: a pilot study. An Bras Dermatol. 2012;87(6):936\u20138.","journal-title":"An Bras Dermatol"},{"issue":"4","key":"91_CR35","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","volume":"59","author":"JE Revuz","year":"2008","unstructured":"Revuz JE, Canoui-Poitrine F, Wolkenstein P, Viallette C, Gabison G, Pouget F, et al. Prevalence and factors associated with hidradenitis suppurativa: results from two case\u2013control studies. J Am Acad Dermatol. 2008;59(4):596\u2013601.","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"91_CR36","doi-asserted-by":"crossref","first-page":"846","DOI":"10.7326\/0003-4819-157-12-201212180-00004","volume":"157","author":"AB Kimball","year":"2012","unstructured":"Kimball AB, Kerdel F, Adams D, Mrowietz U, Gelfand JM, Gniadecki R, et al. Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial. Ann Intern Med. 2012;157(12):846\u201355.","journal-title":"Ann Intern Med"},{"issue":"4","key":"91_CR37","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2133.2009.09198.x","volume":"161","author":"K Sartorius","year":"2009","unstructured":"Sartorius K, Emtestam L, Jemec GB, Lapins J. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. Br J Dermatol. 2009;161(4):831\u20139.","journal-title":"Br J Dermatol"},{"key":"91_CR38","doi-asserted-by":"crossref","unstructured":"Miller I, Ellervik C, Vinding G, Zarchi K, Ibler KS, Knudsen KM, et al. Metabolic syndrome and inflammatory dermatological diseases\u2014Hidradenitis Suppurativa. JAMA Dermatol. (In Press 2014).","DOI":"10.1001\/jamadermatol.2014.1165"},{"key":"91_CR39","doi-asserted-by":"crossref","unstructured":"Scheinfeld N. Topical treatments of skin pain: a general review with a focus on hidradenitis suppurativa with topical agents. Dermatol Online J. 2014; 20(7).","DOI":"10.5070\/D3207023131"},{"issue":"5","key":"91_CR40","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-4362.1983.tb02150.x","volume":"22","author":"OJ Clemmensen","year":"1983","unstructured":"Clemmensen OJ. Topical treatment of hidradenitis suppurativa with clindamycin. Int J Dermatol. 1983;22(5):325\u20138.","journal-title":"Int J Dermatol"},{"issue":"1","key":"91_CR41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2230.2009.03377.x","volume":"35","author":"J Boer","year":"2010","unstructured":"Boer J, Jemec GB. Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa. Clin Exp Dermatol. 2010;35(1):36\u201340.","journal-title":"Clin Exp Dermatol"},{"issue":"157","key":"91_CR42","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/adc.31.157.173","volume":"31","author":"AA Cunningham","year":"1956","unstructured":"Cunningham AA. Resorcin poisoning. Arch Dis Child. 1956;31(157):173\u20136.","journal-title":"Arch Dis Child"},{"key":"91_CR43","doi-asserted-by":"crossref","unstructured":"Jahns AC, Killasli H, Nosek D, Lundskog B, Lenngren A, Muratova Z, et al. Microbiology of hidradenitis suppurativa (acne inversa): a histological study of 27 patients. APMIS. 2014.","DOI":"10.1111\/apm.12220"},{"issue":"4","key":"91_CR44","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1365-2133.2011.10747.x","volume":"166","author":"K Sartorius","year":"2012","unstructured":"Sartorius K, Killasli H, Oprica C, Sullivan A, Lapins J. Bacteriology of hidradenitis suppurativa exacerbations and deep tissue cultures obtained during carbon dioxide laser treatment. Br J Dermatol. 2012;166(4):879\u201383.","journal-title":"Br J Dermatol"},{"issue":"2","key":"91_CR45","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/QCO.0b013e3283428d07","volume":"24","author":"S Yazdanyar","year":"2011","unstructured":"Yazdanyar S, Jemec GB. Hidradenitis suppurativa: a review of cause and treatment. Curr Opin Infect Dis. 2011;24(2):118\u201323.","journal-title":"Curr Opin Infect Dis"},{"issue":"6","key":"91_CR46","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0190-9622(98)70272-5","volume":"39","author":"GB Jemec","year":"1998","unstructured":"Jemec GB, Wendelboe P. Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol. 1998;39(6):971\u20134.","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 1","key":"91_CR47","first-page":"S19","volume":"19","author":"H Keller","year":"1991","unstructured":"Keller H. Comparison of the adverse effect profile of different substances such as penicillins, tetracyclines, sulfonamides and quinolones. Infection. 1991;19(Suppl 1):S19\u201324.","journal-title":"Infection"},{"issue":"6","key":"91_CR48","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.phrs.2011.04.001","volume":"64","author":"R Joks","year":"2011","unstructured":"Joks R, Durkin HG. Non-antibiotic properties of tetracyclines as anti-allergy and asthma drugs. Pharmacol Res. 2011;64(6):602\u20139.","journal-title":"Pharmacol Res"},{"issue":"2","key":"91_CR49","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1574-695X.2009.00625.x","volume":"58","author":"Y Gu","year":"2010","unstructured":"Gu Y, Lee HM, Sorsa T, Simon SR, Golub LM. Doxycycline [corrected] inhibits mononuclear cell-mediated connective tissue breakdown. FEMS Immunol Med Microbiol. 2010;58(2):218\u201325.","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"3","key":"91_CR50","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0738-081X(99)00128-5","volume":"18","author":"Y Miyachi","year":"2000","unstructured":"Miyachi Y. Pharmacologic modulation of neutrophil functions. Clin Dermatol. 2000;18(3):369\u201373.","journal-title":"Clin Dermatol"},{"issue":"1","key":"91_CR51","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/jdv.12127","volume":"28","author":"V Bettoli","year":"2014","unstructured":"Bettoli V, Zauli S, Borghi A, Toni G, Minghetti S, Ricci M, et al. Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: a prospective study on 23 patients. J Eur Acad Dermatol Venereol. 2014;28(1):125\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"91_CR52","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000228337","volume":"219","author":"HH Zee van der","year":"2009","unstructured":"van der Zee HH, Boer J, Prens EP, Jemec GB. The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa. Dermatology. 2009;219(2):143\u20137.","journal-title":"Dermatology"},{"issue":"2","key":"91_CR53","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000228334","volume":"219","author":"G Gener","year":"2009","unstructured":"Gener G, Canoui-Poitrine F, Revuz JE, Faye O, Poli F, Gabison G, et al. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients. Dermatology. 2009;219(2):148\u201354.","journal-title":"Dermatology"},{"issue":"5","key":"91_CR54","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1365-2133.2006.07155.x","volume":"154","author":"CO Mendonca","year":"2006","unstructured":"Mendonca CO, Griffiths CE. Clindamycin and rifampicin combination therapy for hidradenitis suppurativa. Br J Dermatol. 2006;154(5):977\u20138.","journal-title":"Br J Dermatol"},{"issue":"1","key":"91_CR55","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2174\/1874467210801010068","volume":"1","author":"SC Tauber","year":"2008","unstructured":"Tauber SC, Nau R. Immunomodulatory properties of antibiotics. Curr Mol Pharmacol. 2008;1(1):68\u201379.","journal-title":"Curr Mol Pharmacol"},{"issue":"4","key":"91_CR56","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1128\/AAC.05552-11","volume":"56","author":"TU Furustrand","year":"2012","unstructured":"Furustrand TU, Corvec S, Betrisey B, Zimmerli W, Trampuz A. Role of rifampin against Propionibacterium acnes biofilm in vitro and in an experimental foreign-body infection model. Antimicrob Agents Chemother. 2012;56(4):1885\u201391.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"91_CR57","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ijantimicag.2008.08.029","volume":"33","author":"K Smith","year":"2009","unstructured":"Smith K, Perez A, Ramage G, Gemmell CG, Lang S. Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin. Int J Antimicrob Agents. 2009;33(4):374\u20138.","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"91_CR58","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1365-2133.1996.tb07942.x","volume":"134","author":"JH Barth","year":"1996","unstructured":"Barth JH, Layton AM, Cunliffe WJ. Endocrine factors in pre- and postmenopausal women with hidradenitis suppurativa. Br J Dermatol. 1996;134(6):1057\u20139.","journal-title":"Br J Dermatol"},{"issue":"4","key":"91_CR59","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2133.1993.tb03174.x","volume":"129","author":"F Lewis","year":"1993","unstructured":"Lewis F, Messenger AG, Wales JK. Hidradenitis suppurativa as a presenting feature of premature adrenarche. Br J Dermatol. 1993;129(4):447\u20138.","journal-title":"Br J Dermatol"},{"issue":"3","key":"91_CR60","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2133.1986.tb05741.x","volume":"115","author":"RS Sawers","year":"1986","unstructured":"Sawers RS, Randall VA, Ebling FJ. Control of hidradenitis suppurativa in women using combined antiandrogen (cyproterone acetate) and oestrogen therapy. Br J Dermatol. 1986;115(3):269\u201374.","journal-title":"Br J Dermatol"},{"issue":"3","key":"91_CR61","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2133.1986.tb05740.x","volume":"115","author":"PS Mortimer","year":"1986","unstructured":"Mortimer PS, Dawber RP, Gales MA, Moore RA. A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br J Dermatol. 1986;115(3):263\u20138.","journal-title":"Br J Dermatol"},{"issue":"6515","key":"91_CR62","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/bmj.292.6515.245","volume":"292","author":"PS Mortimer","year":"1986","unstructured":"Mortimer PS, Dawber RP, Gales MA, Moore RA. Mediation of hidradenitis suppurativa by androgens. Br Med J (Clin Res Ed). 1986;292(6515):245\u20138.","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"12","key":"91_CR63","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/bjs.1800721223","volume":"72","author":"BJ Harrison","year":"1985","unstructured":"Harrison BJ, Kumar S, Read GF, Edwards CA, Scanlon MF, Hughes LE. Hidradenitis suppurativa: evidence for an endocrine abnormality. Br J Surg. 1985;72(12):1002\u20134.","journal-title":"Br J Surg"},{"issue":"6665","key":"91_CR64","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/bmj.298.6665.28","volume":"298","author":"AJ Stellon","year":"1989","unstructured":"Stellon AJ, Wakeling M. Hidradenitis suppurativa associated with use of oral contraceptives. BMJ. 1989;298(6665):28\u20139.","journal-title":"BMJ"},{"issue":"6","key":"91_CR65","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2230.1996.tb00145.x","volume":"21","author":"GB Jemec","year":"1996","unstructured":"Jemec GB, Heidenheim M, Nielsen NH. Hidradenitis suppurativa\u2014characteristics and consequences. Clin Exp Dermatol. 1996;21(6):419\u201323.","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"91_CR66","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2133.2011.10339.x","volume":"165","author":"I Miller","year":"2011","unstructured":"Miller I, Lynggaard CD, Lophaven S, Zachariae C, Dufour DN, Jemec GB. A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa. Br J Dermatol. 2011;165(2):391\u20138.","journal-title":"Br J Dermatol"},{"issue":"2","key":"91_CR67","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2009.06.050","volume":"62","author":"A Grant","year":"2010","unstructured":"Grant A, Gonzalez T, Montgomery MO, Cardenas V, Kerdel FA. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial. J Am Acad Dermatol. 2010;62(2):205\u201317.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"91_CR68","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jaad.2008.11.898","volume":"60","author":"RA Lee","year":"2009","unstructured":"Lee RA, Dommasch E, Treat J, Sciacca-Kirby J, Chachkin S, Williams J, et al. A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa. J Am Acad Dermatol. 2009;60(4):565\u201373.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"91_CR69","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0190-9622(99)70530-X","volume":"40","author":"J Boer","year":"1999","unstructured":"Boer J, van Gemert MJ. Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa. J Am Acad Dermatol. 1999;40(1):73\u20136.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"91_CR70","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000182261","volume":"218","author":"A Soria","year":"2009","unstructured":"Soria A, Canoui-Poitrine F, Wolkenstein P, Poli F, Gabison G, Pouget F, et al. Absence of efficacy of oral isotretinoin in hidradenitis suppurativa: a retrospective study based on patients\u2019 outcome assessment. Dermatology. 2009;218(2):134\u20135.","journal-title":"Dermatology"},{"issue":"1","key":"91_CR71","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/bjd.12884","volume":"171","author":"L Matusiak","year":"2014","unstructured":"Matusiak L, Bieniek A, Szepietowski JC. Acitretin treatment for hidradenitis suppurativa: a prospective series of 17 patients. Br J Dermatol. 2014;171(1):170\u20134.","journal-title":"Br J Dermatol"},{"issue":"1","key":"91_CR72","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2133.2010.10071.x","volume":"164","author":"J Boer","year":"2011","unstructured":"Boer J, Nazary M. Long-term results of acitretin therapy for hidradenitis suppurativa. Is acne inversa also a misnomer? Br J Dermatol. 2011;164(1):170\u20135.","journal-title":"Br J Dermatol"},{"issue":"2","key":"91_CR73","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1067\/S0190-9622(03)01564-0","volume":"49","author":"AR Brecher","year":"2003","unstructured":"Brecher AR, Orlow SJ. Oral retinoid therapy for dermatologic conditions in children and adolescents. J Am Acad Dermatol. 2003;49(2):171\u201382.","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"91_CR74","first-page":"812","volume":"8","author":"M Stahle","year":"2010","unstructured":"Stahle M, Atakan N, Boehncke WH, Chimenti S, Dauden E, Giannetti A, et al. Juvenile psoriasis and its clinical management: a European expert group consensus. J Dtsch Dermatol Ges. 2010;8(10):812\u20138.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"3","key":"91_CR75","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jaad.2009.12.018","volume":"63","author":"HH Zee van der","year":"2010","unstructured":"van der Zee HH, Prens EP, Boer J. Deroofing: a tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions. J Am Acad Dermatol. 2010;63(3):475\u201380.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"91_CR76","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1524-4725.2011.02255.x","volume":"38","author":"S Hattem van","year":"2012","unstructured":"van Hattem S, Spoo JR, Horvath B, Jonkman MF, Leeman FW. Surgical treatment of sinuses by deroofing in hidradenitis suppurativa. Dermatol Surg. 2012;38(3):494\u20137.","journal-title":"Dermatol Surg"},{"key":"91_CR77","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-5945-12-9","volume":"12","author":"Z Alharbi","year":"2012","unstructured":"Alharbi Z, Kauczok J, Pallua N. A review of wide surgical excision of hidradenitis suppurativa. BMC Dermatol. 2012;12:9.","journal-title":"BMC Dermatol"},{"issue":"5","key":"91_CR78","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/bjs.1800740535","volume":"74","author":"JC Dalrymple","year":"1987","unstructured":"Dalrymple JC, Monaghan JM. Treatment of hidradenitis suppurativa with the carbon dioxide laser. Br J Surg. 1987;74(5):420.","journal-title":"Br J Surg"},{"issue":"3","key":"91_CR79","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0190-9622(96)90441-7","volume":"34","author":"EM Finley","year":"1996","unstructured":"Finley EM, Ratz JL. Treatment of hidradenitis suppurativa with carbon dioxide laser excision and second-intention healing. J Am Acad Dermatol. 1996;34(3):465\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"91_CR80","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1067\/mjd.2002.124601","volume":"47","author":"J Lapins","year":"2002","unstructured":"Lapins J, Sartorius K, Emtestam L. Scanner-assisted carbon dioxide laser surgery: a retrospective follow-up study of patients with hidradenitis suppurativa. J Am Acad Dermatol. 2002;47(2):280\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"91_CR81","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1524-4725.2009.01427.x","volume":"36","author":"PG Hazen","year":"2010","unstructured":"Hazen PG, Hazen BP. Hidradenitis suppurativa: successful treatment using carbon dioxide laser excision and marsupialization. Dermatol Surg. 2010;36(2):208\u201313.","journal-title":"Dermatol Surg"},{"issue":"3","key":"91_CR82","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0022-3468(84)80179-7","volume":"19","author":"I Kaplan","year":"1984","unstructured":"Kaplan I, Sarig A, Taube E, Ben-Bassat M. The CO2 laser in pediatric surgery. J Pediatr Surg. 1984;19(3):248\u201357.","journal-title":"J Pediatr Surg"},{"issue":"2","key":"91_CR83","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/00042728-200802000-00012","volume":"34","author":"MG Buimer","year":"2008","unstructured":"Buimer MG, Ankersmit MF, Wobbes T, Klinkenbijl JH. Surgical treatment of hidradenitis suppurativa with gentamicin sulfate: a prospective randomized study. Dermatol Surg. 2008;34(2):224\u20137.","journal-title":"Dermatol Surg"},{"issue":"4","key":"91_CR84","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000329023","volume":"222","author":"S Yazdanyar","year":"2011","unstructured":"Yazdanyar S, Boer J, Ingvarsson G, Szepietowski JC, Jemec GB. Dapsone therapy for hidradenitis suppurativa: a series of 24 patients. Dermatology. 2011;222(4):342\u20136.","journal-title":"Dermatology"},{"issue":"2","key":"91_CR85","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/bjd.12104","volume":"168","author":"JL Blok","year":"2013","unstructured":"Blok JL, van Hattem S, Jonkman MF, Horvath B. Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review. Br J Dermatol. 2013;168(2):243\u201352.","journal-title":"Br J Dermatol"},{"issue":"9","key":"91_CR86","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1468-3083.2012.04668.x","volume":"27","author":"R Verdolini","year":"2013","unstructured":"Verdolini R, Clayton N, Smith A, Alwash N, Mannello B. Metformin for the treatment of hidradenitis suppurativa: a little help along the way. J Eur Acad Dermatol Venereol. 2013;27(9):1101\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"91_CR87","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/archdermatol.2011.315","volume":"148","author":"B Dreno","year":"2012","unstructured":"Dreno B, Khammari A, Brocard A, Moyse D, Blouin E, Guillet G, et al. Hidradenitis suppurativa: the role of deficient cutaneous innate immunity. Arch Dermatol. 2012;148(2):182\u20136.","journal-title":"Arch Dermatol"},{"issue":"5","key":"91_CR88","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1097\/01.prs.0000184354.32111.dc","volume":"116","author":"DJ O\u2019Reilly","year":"2005","unstructured":"O\u2019Reilly DJ, Pleat JM, Richards AM. Treatment of hidradenitis suppurativa with botulinum toxin A. Plast Reconstr Surg. 2005;116(5):1575\u20136.","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"91_CR89","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/ced.12380","volume":"39","author":"AB Khoo","year":"2014","unstructured":"Khoo AB, Burova EP. Hidradenitis suppurativa treated with Clostridium botulinum toxin A. Clin Exp Dermatol. 2014;39(6):749\u201350.","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"91_CR90","first-page":"21","volume":"147","author":"LY Xu","year":"2011","unstructured":"Xu LY, Wright DR, Mahmoud BH, Ozog DM, Mehregan DA, Hamzavi IH. Histopathologic study of hidradenitis suppurativa following long-pulsed 1064-nm Nd:YAG laser treatment. Arch Dermatol. 2011;147(1):21\u20138.","journal-title":"Arch Dermatol"},{"issue":"8","key":"91_CR91","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1524-4725.2009.01214.x","volume":"35","author":"E Tierney","year":"2009","unstructured":"Tierney E, Mahmoud BH, Hexsel C, Ozog D, Hamzavi I. Randomized control trial for the treatment of hidradenitis suppurativa with a neodymium-doped yttrium aluminium garnet laser. Dermatol Surg. 2009;35(8):1188\u201398.","journal-title":"Dermatol Surg"},{"issue":"2","key":"91_CR92","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/PRS.0b013e31821e6fb5","volume":"128","author":"L Highton","year":"2011","unstructured":"Highton L, Chan WY, Khwaja N, Laitung JK. Treatment of hidradenitis suppurativa with intense pulsed light: a prospective study. Plast Reconstr Surg. 2011;128(2):459\u201365.","journal-title":"Plast Reconstr Surg"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-014-0091-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-014-0091-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-014-0091-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T17:05:16Z","timestamp":1689527116000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-014-0091-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,19]]},"references-count":92,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["91"],"URL":"https:\/\/doi.org\/10.1007\/s40272-014-0091-3","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,19]]}}}